Processa Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Processa Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2012 to Q3 2024.
  • Processa Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 100M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 100M 0 0% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 100M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 100M +50M +100% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 100M +50M +100% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 100M +50M +100% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 100M +50M +100% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 50M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 50M +20M +66.7% Dec 31, 2022 10-K 2024-03-29
Q3 2022 50M +20M +66.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 50M +20M +66.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 50M +20M +66.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 30M 0 0% Dec 31, 2021 10-K 2023-03-30
Q3 2021 30M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 30M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 30M -70M -70% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 30M -70M -70% Dec 31, 2020 10-K 2022-03-30
Q3 2020 30M -70M -70% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 30M -320M -91.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 100M -250M -71.4% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 100M -250M -71.4% Dec 31, 2019 10-K 2021-03-25
Q3 2019 100M -250M -71.4% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 350M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 350M 0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 350M +307M +709% Dec 31, 2018 10-K 2020-03-06
Q3 2018 350M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 350M +330M +1650% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 350M +330M +1650% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 43.3M 0 0% Dec 31, 2017 10-K/A 2019-04-08
Q3 2017 350M +330M +1650% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 20M 0 0% Jun 30, 2017 10-Q 2017-10-04
Q1 2017 20M 0 0% Mar 31, 2017 10-Q 2017-10-04
Q4 2016 43.3M +23.3M +116% Dec 31, 2016 10-K 2018-04-16
Q3 2016 20M 0 0% Sep 30, 2016 10-Q 2017-09-08
Q2 2016 20M 0 0% Jun 30, 2016 10-Q 2017-08-30
Q1 2016 20M 0 0% Mar 31, 2016 10-Q 2017-08-07
Q4 2015 20M 0 0% Dec 31, 2015 10-K 2017-09-25
Q3 2015 20M 0 0% Sep 30, 2015 10-Q 2015-12-01
Q2 2015 20M 0 0% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 20M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 20M 0 0% Dec 31, 2014 10-K 2017-06-19
Q3 2014 20M 0 0% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 20M 0 0% Jun 30, 2014 10-Q 2014-08-19
Q1 2014 20M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 20M 0 0% Dec 31, 2013 10-K 2015-04-14
Q3 2013 20M Sep 30, 2013 10-Q 2013-11-08
Q2 2013 20M Jun 30, 2013 10-Q/A 2013-09-06
Q4 2012 20M Dec 31, 2012 10-K 2014-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.